Prevention of ACTH- and adrenalectomy-induced muricidal behavior: By benzodiazepinic ligands

Peptides

Volumn 18, Issue 2, 1997, Pages 185-189

  Miachon, S ^a   Cespuglio, R ^a  

^a INSERM   (France)

Author keywords

ACTH; Adrenalectomy; Aggressivity; Central and peripheral benzodiazepines

Indexed keywords

4' CHLORODIAZEPAM; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; CORTICOTROPIN; FLUMAZENIL; MUSCIMOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ADRENALECTOMY; AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE;

ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; AGGRESSION; ANIMALS; BENZODIAZEPINONES; CLONAZEPAM; FLUMAZENIL; GABA MODULATORS; ISOQUINOLINES; MALE; MICE; MUSCIMOL; RATS; RATS, WISTAR; RECEPTORS, GABA-A; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030971633     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00293-8     Document Type: Article

References (52)

1. Agmo A., Pruneda R., Guzman M., Gutierrez M. GABAergic drugs and conflict behavior in the rat: Lack of similarities with the actions of benzodiazepines. Arch. Pharmacol. 344:1991;314-322.
2. Banks W., Kastin A. Permeability of the blood-brain barrier to melanocortins. Peptides. 16:1995;1157-1161.
3. Barret P, Mac Donald A., Helliwell R., Davidson G., Morgan P. Cloning and expression of a new member of the melanocyte-stimulating hormone receptor family. J. Mol. Endocrinol. 12:1994;203-213.
4. 3H PK 11195, an isoquinoline carboxamide derivative: Kinetic studies and autoradiographic localization. J. Neurochem. 41:1983;1744-1750.
5. Bonetti E., Pieri L., Cumin R., Schaffner R., Pieri M., Gamzu E., Müller R. K. M., Haefly W. Benzodiazepine antagonist RO 15-1788: Neurological and behavioral effects. Psychopharmacology (Berlin). 78:1982;8-18.
6. Braestrup C., Nielsen M. Benzodiazepine receptor binding in vivo and efficacy. Olsen R. W., Craig Venter J. Benzodiazepine/GABA receptors and chloride channels. 1986;167-184 Alan Liss Inc, New York.
7. Calogero A. E., Kamilaris T. C., Bernardini R., Johnson E. O., Chrousos G. P., Gold P. W. Effects of peripheral benzodiazepine receptor ligands on hypothalamic pituitary-adrenal axis function in the rat. J. Pharmacol. Exp. Ther. 253:1990;729-737.
8. Calogero A. E., Kamilaris T. C., Johnson E. O., Gold P. W., Chrousos G. P. Peripheral benzodiazepine receptor ligands stimulate prolactin release in the rat. J. Neuroendocrinol. 2:1990;754-760.
9. A receptors. Neuropsychopharmacology. 4:1991;225-235.
10. Costa E., Guidotti A. Diazepam binding inhibitor (DBI): A peptide with multiple biological actions. Life Sci. 49:1991;325-344.
11. Curran T., Morgan J. I. Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science. 1985;1265-1268.
12. Dantzer R., Perio A. Behavioral evidence for partial agonist properties of RO 15-1788, a benzodiazepine receptor antagonist. Eur. J. Pharmacol. 81:1982;655-658.
13. Ferrarese C., Appolinio I., Bianchi G., Frigo M., Marzorati C., Pecora N., Perego M., Pierpaoli C., Frattola L. Benzodiazepine receptors and diazepam binding inhibitor: A possible link between stress, anxiety, and the immune system. Psychoneuroendocrinology. 18:1993;3-22.
14. Ferrero P., Santi M. R., Conti-Tronconi B., Costa E., Guidotti A. Study of an octadecaneuropeptide derived from diazepam-binding inhibitor: Biological activity and presence in the brain. Proc. Natl. Acad. Sci. USA. 83:1986;827-831.
15. File S. E., Pellow S. Intrinsic action of the benzodiazepine receptor antagonist RO 15-1788. Psychopharmacology (Berlin). 88:1986;1-11.
16. File S. E., Baldwin H. A. Effects of β carbolines in animal models of anxiety. Br. Res. Bull. 19:1987;293-299.
17. Grange E., Lepetit P., Baubet V., Giaume M., Leclerc M., Gay N., Gagnon J., Bobillier P. Adrenalectomy-induced increase of brain protein synthesis is antagonized by corticosterone replacements in free-moving rats. J. Neurochem. 62:1994;1079-1088.
18. Guarneri P., Papadopoulos V., Pan B., Costa E. Regulation of pregnenolone synthesis in C6-2B glioma cells by 4′-chlorodiazepam. Proc. Natl. Acad. Sci. USA. 89:1992;5118-5122.
19. Holmes P. V., Drugan R. C. Differential effects of anxiogenic central and peripheral receptor ligands in tests of learning and memory. Psychopharmacology (Berlin). 104:1991;249-254.
20. Hunkeller W., Mohler H., Pieri L., Polc P., Bonetti E. P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 290:1981;514-516.
21. 3H glutamate binding sites and GABA/benzodiazepine/picrotoxin receptor complexes in vitro. Brain Dev. 10:1988;106-109.
22. Kaijima M., Le Gal la Salle G., Rossier J. The partial benzodiazepine agonist properties of RO 15-1788 in pentylenetetrazol-induced seizures in cats. Eur. J. Pharmacol. 93:1983;113-115.
23. 3H GABA receptor binding in rat brain. Brain Res. 236:1982;365-374.
24. Le Fur G., Perrier M. L., Vaucher N., Imbault F., Flamier A., Benavides J., Uzan A., Renault C., Dubroeucq M. C., Guérémy C. Peripheral benzodiazepine binding sites: Effect of PK 11195. In vitro studies. Life Sci. 32:1983;1839-1847.
25. Lippa A. S., Greenblatt E. N., Pelham R. W. The use of animal models for delineating the mechanisms of action of anxiolytic agents. Hanin, Usdin. Animal models in psychiatry and neurology. 1977;279-292 Pergamon Press, New York.
26. A receptors in brain. Brain Res. 339:1985;178-182.
27. Mandel P., Ciesielski L., Maitre M., Simler S., Mack G., Kempf E. Involvment of central GABA-ergic systems in convulsions and aggressive behavior. Adv. Exp. Med. Biol. 123:1979;475-492.
28. 3H RO 5-4864. Mol. Pharmacol. 22:1982;26.
29. Medina J. M., Novas M. L., De Robertis E. Regulation of the benzodiazepine receptor: In vivo and in vitro experiments. Biggio G., Costa E. GABAergic transmission and anxiety. 1986;Raven Press, New York.
30. Miachon S., Claustrat B., Cespuglio R. Induction of muricidal behavior by ACTH or adrenalectomy in young male Wistar rats. Brain Res. Bull. 36:1995;119-123.
31. Miachon S., Manchon M., Fromentin J. R., Buda M. Isolation-induced changes in radioligand binding to benzodiazepine binding sites. Neurosci. Lett. 111:1990;246-251.
32. Miachon S., Rochet T., Mathian B., Barbagli B., Claustrat B. Long term isolation of Wistar rats alters monoamine turnover, blood corticosterone and ACTH. Brain Res. Bull. 32:1993;611-614.
33. Miller L. G., Greenblatt D. J., Barnhill J. G., Thompson M. L., Shaderh R. I. Modulation of benzodiazepine receptor binding in mouse brain by adrenalectomy and steroid replacement. Brain Res. 446:1988;314-320.
34. Mizoule J., Gauthier A., Uzan A., Renault C., Dubroeucq M. C., Guérémy C., Le Fur G. Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO 5-4864, in a conflict situation in the rat. Life Sci. 36:1985;1059-1068.
35. Mukhin A., Papadopoulos V., Costa E., Krueger K. E. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc. Natl. Acad. Sci. USA. 86:1989;9813-9816.
36. Oliver C., Mical R. S., Porter J. C. Hypothalamic-pituitary vasculature. Evidence for retrograde blood flow in the pituitary stalk. Endocrinology. 101:1977;598-604.
37. Owens M. J., Vargas M. A., Knight D. L., Nemeroff C. B. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: Acute time couse, chronic treatment and abrupt withdrawal. J. Pharmacol. Exp. Ther. 258:1991;349-356.
38. Pellow S., File S. E. Behavioral actions of RO 5-4864: A peripheral type benzodiazepine? Life Sci. 35:1984;229-240.
39. Rägo L., Kiivet R. A., Harro J., Pòld M. Central- and peripheral-type benzodiazepine receptors: Similar regulation by stress and GABA receptor agonists. Pharmacol. Biochem. and Behav. 32:1989;879-883.
40. Robel P., Baulieu E. E. Les neurostéroides: Une nouvelle fonction du cerveau? Med. Sci. 6:1990;252-260.
41. Rohrer T., von Richthofen V., Schulz C., Beyer J., Lehnert H. The stress-, but not corticotropin-releasing hormone-induced activation of the HPA in man is blocked by alprazolam. Horm. Metab. Res. 26:1994;200-206.
42. Sever'ianova L. A., Plotnikov D. V. Effect of ACTH fragments on the aggressive-defensive behavior of the rat. Fiziol. Zh. 72:1986;1614-1618.
43. De Souza E. B., Goeders N. E., Kuhar M. Benzodiazepine receptors in rat brain are altered by adrenalectomy. Brain Res. 381:1986;176-181.
44. Spruijt B. M., Cools A. R., Gispen W. H. The periacqueductal gray: A prerequisite for ACTH-induced excessive grooming. Behav. Brain Res. 20:1986;19-25.
45. A receptors coupled to t-35 S-butylbicyclo-phosphorothionate binding sites: Possible involvement with seizures associated with hereditary amino acidemias. J. Neurochem. 51:1988;837-842.
46. Tatro J. B., Entwistle M. L. Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ. Brain Res. 635:1994;148-158.
47. Tonon M. C., Smith-Rouet F., Lamacz M., Louiset E., Pelletier G., Vaudry H. Les endozepines, ligands endogènes des recepteurs des benzodiazepines. Med. Sci. 10:1994;433-443.
48. Traber J., Spencer D. G., Glaser T., Gispen W. H. Actions of psychoactive drugs on ACTH and novelty-induced behavior in the rat. Ann. NY Acad. Sci. 1988;525-570.
49. Uht R. M., Thompson R. C., Douglass J. O., Mc Kelvy J. F. Changes in CRF mRNA levels following adrenalectomy. Breznitz S., Zinder O. Molecular biology of stress. 1989;49-55 Alan R. Liss, New York.
50. Walsh L. L. Strain and sex differences in mouse killing by rats. J. Comp. Physiol. Psychol. 96:1982;278-283.
51. Weissman B. A., Cott J., Hommer D., Paul S., Skolnick P. Electrophysical and pharmacological actions of the convulsant benzodiazepine RO 5 4864. Eur. J. Pharmacol. 97:1984;257-263.
52. Whitehouse B. J. Benzodiazepine and steroidogenesis. J. Endocrinol. 134:1992;1-3.